Rectal Cancer Disappears After Experimental Use of Immunotherapy
Posted:
12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.
Rare diseases pose a significant challenge for health care professionals. These conditions — often complex and elusive — lead patients through a lengthy journey before a diagnosis is finally reached. The process is riddled with uncertainties, as symptoms usually mimic…
Apple is giving more people the chance to test a software update that will implant artificial intelligence into its virtual assistant Siri and automate a variety of tedious tasks on the latest iPhone coming out Friday.
Read the full article…